Meglasson Martin - Insider Stock Trading - OpenInsider

CIK: 1280564 - Address: C/o Bellerophon Therapeutics, Inc., 53 Frontage Road, Suite 301, Hampton, NJ 08827

6 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	2	1	6	1	8	-0	-12	-42	-37	-14
P	%wins				83	67	33	17	17	17	39

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
5/22/15 07:32	5/20/15	BLPH	Bellerophon Therapeutics, Inc.		Health	Drug	Pharmaceutical Preparations	Meglasson Martin	NJ	O	Chief Sc	P	6	8.40	0	1	4	19	D				-4	-9	-3	4	10	0	3	-16	-39	-68	-86
2/23/15 21:39	2/19/15	BLPH	Bellerophon Therapeutics, Inc.		Health	Drug	Pharmaceutical Preparations	Meglasson Martin	NJ	O	Chief Sc	P	144	12.00	3	12	188	18	D								2	-2	25	6	-6	-44	-78
5/11/10 14:14	5/11/10	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Meglasson Martin	CA	O	V-P,Disc	P	10	1.63	0	6	7	102	D	-51	-46	-13	6	-4	-7	-12	-10	0	-2	-6	-3	1	10
5/9/08 13:53	5/9/08	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Meglasson Martin	CA	O	V-P,Disc	P	10	3.36	0	3	9	37	D	-61	-51	-37	-21	-13	-17	-18	-9	0	4	-7	-12	-57	-10
8/30/07 19:04	8/30/07	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Meglasson Martin	CA	O	V-P,Disc	P	12	6.19	1	2	17	14	D	3	-15	-29	-8	-11	0	0	-7	0	-1	-15	-28	-47	-47
11/12/04 17:11	11/11/04	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Meglasson Martin	CA	O	V-P,Disc	P	4	8.82	2	1	New	1	D	29	-29	-48	4	-12	3	4	-6	8	19	36	19	-34	-10

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact